{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:43:59Z","timestamp":1793295839847,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772991, 81572466, and 81372564"],"award-info":[{"award-number":["81772991, 81572466, and 81372564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772884"],"award-info":[{"award-number":["81772884"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long non-coding RNAs (lncRNAs) play vital roles in the development and progression of non-small-cell lung cancer (NSCLC); however, the role of most lncRNAs in NSCLC remains unknown. This study explored the clinical significance, biological function and underlying mechanism of lnc-GAN1 in NSCLC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>With a custom lncRNA microarray we found that lnc-GAN1 is markedly downregulated in NSCLC tissues. Then lnc-GAN1 expression level was measured using qRT-PCR in NSCLC tissues and cell lines. Survival was assessed using the Kaplan-Meier method. The biological functions of lnc-GAN1 in lung cancer cells were evaluated in vitro and in vivo. RNA fluorescence in situ hybridization and subcellular localization assays revealed the subcellular distribution of lnc-GAN1 in cells. Bioinformatic analysis was adopted to predict miRNAs and signaling pathways regulated by lnc-GAN1. RNA immunoprecipitation and Dual-luciferase reporter assays were used to assess the interaction between lnc-GAN1 and miR-26a-5p in lung cancer cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>lnc-GAN1 is downregulated in HCC tissues\u00a0and associated with larger tumor size and poor overall survival and disease-free survival; its ectopic expression suppresses cell proliferation, colony formation, and cell cycle progression and induces apoptosis in NSCLC cells; it also inhibits tumor growth in the NSCLC xenograft model. We further proved that lnc-GAN1 is localized in cytoplasm and transcribed independently from its parental gene GAN. Mechanistically, lnc-GAN1 acts as a sponge for miR-26a-5p by two seed sequences, and the two non-coding RNAs have a negative relationship in NSCLC tissues; we further prove that PTEN is a direct target of miR-26a-5p and lnc-GAN1 inhibits cell cycle signaling pathway by activating PTEN, whose expression level correlated negatively with miR-26a-5p level but positively with lnc-GAN1 level in NSCLC samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Lnc-GAN1 is downregulated and associated with poor survival of NSCLC patients, and mechanistically acts as a tumor suppressor via sponging and inhibiting miR-26a-5p to upregulate PTEN. This study provides a potential prognostic biomarker and treatment target for NSCLC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-020-01819-0","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T06:02:59Z","timestamp":1609912979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer"],"prefix":"10.1186","volume":"40","author":[{"given":"Rui-Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ran","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Zhong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Juan","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6728-4376","authenticated-orcid":false,"given":"Hui-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"1819_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, Paz-Ares L. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299\u2013311.","journal-title":"Lancet"},{"key":"1819_CR2","first-page":"19","volume":"41","author":"S-R Zheng","year":"2019","unstructured":"Zheng S-R, Sun K-X, Zhang S-W, Zeng H-M, Zou X-N, Chen R. Analysis of cancer prevalence in China in 2015. Chin J Oncol. 2019;41:19\u201328.","journal-title":"Chin J Oncol"},{"key":"1819_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature"},{"key":"1819_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.33594\/000000026","volume":"52","author":"X Kong","year":"2019","unstructured":"Kong X, Zhao Y, Li X, Tao Z, Hou M, Ma H. Overexpression of HIF-2alpha-dependent NEAT1 promotes the progression of non-small cell lung cancer through miR-101-3p\/SOX9\/Wnt\/beta-catenin signal pathway. Cell Physiol Biochem. 2019;52:368\u201381.","journal-title":"Cell Physiol Biochem"},{"key":"1819_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B, McGraw T, Mittal V. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2019;19:9\u201331.","journal-title":"Nat Rev Cancer"},{"key":"1819_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cell.2011.03.014","volume":"145","author":"T Nagano","year":"2011","unstructured":"Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell. 2011;145:178\u201381.","journal-title":"Cell"},{"key":"1819_CR7","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s00018-013-1423-0","volume":"70","author":"M Kitagawa","year":"2013","unstructured":"Kitagawa M, Kitagawa K, Kotake Y, Niida H, Ohhata T. Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci. 2013;70:4785\u201394.","journal-title":"Cell Mol Life Sci"},{"key":"1819_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904\u201314.","journal-title":"Mol Cell"},{"key":"1819_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272\u201383.","journal-title":"Nat Rev Genet"},{"key":"1819_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146:353\u20138.","journal-title":"Cell"},{"key":"1819_CR11","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96:1297\u2013325.","journal-title":"Physiol Rev"},{"key":"1819_CR12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73:1180\u20139.","journal-title":"Cancer Res"},{"key":"1819_CR13","first-page":"504","volume":"21","author":"SJ Sun","year":"2017","unstructured":"Sun SJ, Lin Q, Ma JX, Shi WW, Yang B, Li F. Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21:504\u201310.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1819_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-014-0090-4","volume":"7","author":"G Loewen","year":"2014","unstructured":"Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7:90.","journal-title":"J Hematol Oncol"},{"key":"1819_CR15","doi-asserted-by":"publisher","first-page":"31093","DOI":"10.1038\/srep31093","volume":"6","author":"Y Wu","year":"2016","unstructured":"Wu Y, Lyu H, Liu H, Shi X, Song Y, Liu B. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer. Sci Rep. 2016;6:31093.","journal-title":"Sci Rep"},{"key":"1819_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-018-0836-7","volume":"17","author":"D Yin","year":"2018","unstructured":"Yin D, Lu X, Su J, He X, De W, Yang J, Li W, Han L, Zhang E. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Mol Cancer. 2018;17:92.","journal-title":"Mol Cancer"},{"key":"1819_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-017-0685-9","volume":"16","author":"W Lu","year":"2017","unstructured":"Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H, Kong J, Ding K, Shen HM, Wu H, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol Cancer. 2017;16:118.","journal-title":"Mol Cancer"},{"key":"1819_CR18","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jtho.2016.07.015","volume":"11","author":"JJ Castellano","year":"2016","unstructured":"Castellano JJ, Navarro A, Vinolas N, Marrades RM, Moises J, Cordeiro A, Saco A, Munoz C, Fuster D, Molins L, et al. LincRNA-p21 impacts prognosis in resected non-small cell lung cancer patients through angiogenesis regulation. J Thorac Oncol. 2016;11:2173\u201382.","journal-title":"J Thorac Oncol"},{"key":"1819_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12967-020-02485-8","volume":"18","author":"RQ Wang","year":"2020","unstructured":"Wang RQ, Long XR, Ge CL, Zhang MY, Huang L, Zhou NN, Hu Y, Li RL, Li Z, Chen DN, et al. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China. J Transl Med. 2020;18:320.","journal-title":"J Transl Med"},{"key":"1819_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/81701","volume":"26","author":"P Bomont","year":"2000","unstructured":"Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, Demir E, Topaloglu H, Korinthenberg R, Tuysuz B, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB\/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet. 2000;26:370\u20134.","journal-title":"Nat Genet"},{"key":"1819_CR21","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1172\/JCI66387","volume":"123","author":"S Mahammad","year":"2013","unstructured":"Mahammad S, Murthy SN, Didonna A, Grin B, Israeli E, Perrot R, Bomont P, Julien JP, Kuczmarski E, Opal P, Goldman RD. Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation. J Clin Invest. 2013;123:1964\u201375.","journal-title":"J Clin Invest"},{"key":"1819_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00439-016-1659-5","volume":"135","author":"JJ Kang","year":"2016","unstructured":"Kang JJ, Liu IY, Wang MB, Srivatsan ES. A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer. Hum Genet. 2016;135:675\u201384.","journal-title":"Hum Genet"},{"key":"1819_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1089\/scd.2014.0353","volume":"24","author":"W Lu","year":"2015","unstructured":"Lu W, Han L, Su L, Zhao J, Zhang Y, Zhang S, Zhao B, Miao J. A 3\u2019UTR-associated RNA, FLJ11812 maintains stemness of human embryonic stem cells by targeting miR-4459. Stem Cells Dev. 2015;24:1133\u201340.","journal-title":"Stem Cells Dev"},{"key":"1819_CR24","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41388-018-0266-4","volume":"37","author":"H Guo","year":"2018","unstructured":"Guo H, Zhao L, Shi B, Bao J, Zheng D, Zhou B, Shi J. GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90. Oncogene. 2018;37:4505\u201317.","journal-title":"Oncogene"},{"key":"1819_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12943-020-01206-5","volume":"19","author":"Y Liang","year":"2020","unstructured":"Liang Y, Song X, Li Y, Chen B, Zhao W, Wang L, Zhang H, Liu Y, Han D, Zhang N, et al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303\/PTBP3 axis. Mol Cancer. 2020;19:85.","journal-title":"Mol Cancer"},{"key":"1819_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-019-0957-7","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p\/FOXA1 axis. Mol Cancer. 2019;18:28.","journal-title":"Mol Cancer"},{"key":"1819_CR27","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1093\/nar\/gkw047","volume":"44","author":"X Zong","year":"2016","unstructured":"Zong X, Nakagawa S, Freier SM, Fei J, Ha T, Prasanth SG, Prasanth KV. Natural antisense RNA promotes 3\u2032 end processing and maturation of MALAT1 lncRNA. Nucleic Acids Res. 2016;44:2898\u2013908.","journal-title":"Nucleic Acids Res"},{"key":"1819_CR28","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/hep.28507","volume":"63","author":"Y Li","year":"2016","unstructured":"Li Y, Tsang CK, Wang S, Li XX, Yang Y, Fu L, Huang W, Li M, Wang HY, Zheng XF. MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription. Hepatology. 2016;63:1928\u201342.","journal-title":"Hepatology"},{"key":"1819_CR29","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/hep.29715","volume":"67","author":"H Zhang","year":"2018","unstructured":"Zhang H, Li XX, Yang Y, Zhang Y, Wang HY, Zheng XFS. Significance and mechanism of androgen receptor overexpression and androgen receptor\/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma. Hepatology. 2018;67:2271\u201386.","journal-title":"Hepatology"},{"key":"1819_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2014.08.018","volume":"159","author":"JM Engreitz","year":"2014","unstructured":"Engreitz JM, Sirokman K, McDonel P, Shishkin AA, Surka C, Russell P, Grossman SR, Chow AY, Guttman M, Lander ES. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent pre-mRNAs and chromatin sites. Cell. 2014;159:188\u201399.","journal-title":"Cell"},{"key":"1819_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejmech.2018.11.076","volume":"164","author":"M Xi","year":"2019","unstructured":"Xi M, Chen T, Wu C, Gao X, Wu Y, Luo X, Du K, Yu L, Cai T, Shen R, Sun H. CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors. Eur J Med Chem. 2019;164:77\u201391.","journal-title":"Eur J Med Chem"},{"key":"1819_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.lungcan.2012.02.017","volume":"77","author":"SM Rausch","year":"2012","unstructured":"Rausch SM, Gonzalez BD, Clark MM, Patten C, Felten S, Liu H, Li Y, Sloan J, Yang P. SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. Lung Cancer. 2012;77:217\u201323.","journal-title":"Lung Cancer"},{"key":"1819_CR33","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1128\/MCB.23.17.6139-6149.2003","volume":"23","author":"A Radu","year":"2003","unstructured":"Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol. 2003;23:6139\u201349.","journal-title":"Mol Cell Biol"},{"key":"1819_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1056\/NEJMra1703413","volume":"377","author":"M Reck","year":"2017","unstructured":"Reck M, Rabe KF. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 2017;377:849\u201361.","journal-title":"N Engl J Med"},{"key":"1819_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jamainternmed.2013.12738","volume":"174","author":"EF Patz Jr","year":"2014","unstructured":"Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC, Chiles C, Black WC, Aberle DR, Team NOMW. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174:269\u201374.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1819_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13059-017-1348-2","volume":"18","author":"FP Marchese","year":"2017","unstructured":"Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017;18(1):206.","journal-title":"Genome Biol"},{"key":"1819_CR37","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1158\/0008-5472.CAN-18-0222","volume":"78","author":"W Su","year":"2018","unstructured":"Su W, Feng S, Chen X, Yang X, Mao R, Guo C, Wang Z, Thomas DG, Lin J, Reddy RM, et al. Silencing of long noncoding RNA MIR22HG triggers cell survival\/death signaling via oncogenes YBX1, MET, and p21 in lung cancer. Cancer Res. 2018;78:3207\u201319.","journal-title":"Cancer Res"},{"key":"1819_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.omtn.2018.12.006","volume":"16","author":"D Wang","year":"2019","unstructured":"Wang D, Hu Y. Long non-coding RNA PVT1 competitively binds MicroRNA-424-5p to regulate CARM1 in radiosensitivity of non-small-cell lung cancer. Mol Ther Nucleic Acids. 2019;16:130\u201340.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1819_CR39","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/1878-0261.12437","volume":"13","author":"S Yuan","year":"2019","unstructured":"Yuan S, Xiang Y, Wang G, Zhou M, Meng G, Liu Q, Hu Z, Li C, Xie W, Wu N, et al. Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer. Mol Oncol. 2019;13:840\u201356.","journal-title":"Mol Oncol"},{"key":"1819_CR40","doi-asserted-by":"publisher","first-page":"22657","DOI":"10.1002\/jcp.28832","volume":"234","author":"S Xing","year":"2019","unstructured":"Xing S, Qu Y, Li C, Huang A, Tong S, Wu C, Fan K. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN\/AKT. J Cell Physiol. 2019;234:22657\u201365.","journal-title":"J Cell Physiol"},{"issue":"7","key":"1819_CR41","doi-asserted-by":"publisher","first-page":"BSR20182192","DOI":"10.1042\/BSR20182192","volume":"39","author":"Z Huang","year":"2019","unstructured":"Huang Z, Xing S, Liu M, Deng W, Wang Y, Huang Z, Huang Y, Huang X, Wu C, Guo X, et al. MiR-26a-5p enhances cells proliferation, invasion, and apoptosis resistance of fibroblast-like synoviocytes in rheumatoid arthritis by regulating PTEN\/PI3K\/AKT pathway. Biosci Rep. 2019;39(7):BSR20182192.","journal-title":"Biosci Rep"},{"key":"1819_CR42","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbrc.2018.05.020","volume":"501","author":"Q Song","year":"2018","unstructured":"Song Q, Liu B, Li X, Zhang Q, Cao L, Xu M, Meng Z, Wu X, Xu K. MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGbeta8- JAK2\/STAT3 axis. Biochem Biophys Res Commun. 2018;501:494\u2013500.","journal-title":"Biochem Biophys Res Commun"},{"key":"1819_CR43","first-page":"4223","volume":"16","author":"H Wang","year":"2018","unstructured":"Wang H, Hu Z, Chen L. Enhanced plasma miR-26a-5p promotes the progression of bladder cancer via targeting PTEN. Oncol Lett. 2018;16:4223\u20138.","journal-title":"Oncol Lett"},{"key":"1819_CR44","doi-asserted-by":"publisher","first-page":"14924","DOI":"10.1073\/pnas.1520329112","volume":"112","author":"P Gasparini","year":"2015","unstructured":"Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, Ali G, D'Incecco A, Minuti G, Chella A, et al. microRNA classifiers are powerful diagnostic\/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Proc Natl Acad Sci U S A. 2015;112:14924\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1819_CR45","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2217\/pgs.15.122","volume":"16","author":"C Perez-Ramirez","year":"2015","unstructured":"Perez-Ramirez C, Canadas-Garre M, Molina MA, Faus-Dader MJ, Calleja-Hernandez MA. PTEN and PI3K\/AKT in non-small-cell lung cancer. Pharmacogenomics. 2015;16:1843\u201362.","journal-title":"Pharmacogenomics"},{"key":"1819_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","volume":"19","author":"YR Lee","year":"2018","unstructured":"Lee YR, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol. 2018;19:547\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1819_CR47","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1146\/annurev-biochem-082411-113907","volume":"83","author":"CA Worby","year":"2014","unstructured":"Worby CA, Dixon JE. Pten. Annu Rev Biochem. 2014;83:641\u201369.","journal-title":"Annu Rev Biochem"},{"key":"1819_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13578-018-0221-7","volume":"8","author":"H Xiao","year":"2018","unstructured":"Xiao H, Liu Y, Liang P, Wang B, Tan H, Zhang Y, Gao X, Gao J. TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a\/PTEN axis. Cell Biosci. 2018;8:23.","journal-title":"Cell Biosci"},{"key":"1819_CR49","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1111\/cas.14136","volume":"110","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yang H, Du Y, Liu P, Zhang J, Li Y, Shen H, Xing L, Xue X, Chen J, Zhang X. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96. Cancer Sci. 2019;110:2760\u201372.","journal-title":"Cancer Sci"},{"key":"1819_CR50","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1073\/pnas.96.11.6199","volume":"96","author":"H Sun","year":"1999","unstructured":"Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt\/protein kinase B signaling pathway. Proc Natl Acad Sci U S A. 1999;96:6199\u2013204.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01819-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-020-01819-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01819-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T07:11:25Z","timestamp":1609917085000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01819-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01819-0","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Ethical Committees of Sun Yat-Sen University Cancer Center. Written informed consent was obtained from each patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to submit the article for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}